Skip to main content

NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

bispecific antibody AMG 509

A bispecific antibody that simultaneously binds to two different and as of yet undisclosed antigens, with potential immunomodulating and antineoplastic activities. Upon administration, AMG 509 targets and binds to the two antigens. This may modulate the tumor microenvironment (TME) and may enhance an immune-mediated antitumor response.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Code name:	AMG 509 AMG-509 AMG509

bispecific antibody AMG 509

Search NCI's Drug Dictionary